You are here

Membrane Oxygenators for Enhancing Bioreactors

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1 R43 GM54385-01,
Agency Tracking Number: 29473
Amount: $99,900.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1995
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
325 Hampton Road
Wilmington, DE 19803
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Stuart Nemser
 () -
Business Contact
Phone: () -
Research Institution
N/A
Abstract

The investigators will develop a new class of perfluoropolymers with exceptionally high oxygen fluxmembranes for enhanced bioreactor performance. Propagation of animal cells for biopharmaceuticals iswidespread along with optimization of environmental constraints and procedures to increase bioreactooxygen availability limits bioreactor cell culture production. Sparging is the choice method to aerawith sensitive animal cells sparging can be counterproductive. Entertainment at liquid/gas interfacecells. Microporous hollow fibers to introduce oxygen also causes shear damage to animal cells. Animaattach to microporous fibers and impede gas transfer. The copolymer of perfluoro-dimethyl-dioxole (Ptetrafluoroethylene (TFE) display membrane permeabilities 40 times higher than conventional membranerubber). The PDD-TFE organophobic and hydrophobic surface should discourage cell surface attachmentinvestigators will make both hollow fiber and flat sheet oxygenator modules which will be evaluatedin bioreactors to determine their oxygen transfer rates, non-plugging characteristics and their abilhaving enhanced oxygen uptake rates.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government